Multiple myeloma with amyloid deposition
Showing 26 - 50 of >10,000
Prognosis Based on cfDNA Methylation in Multiple Myeloma
Recruiting
- Multiple Myeloma
- cfDNA methylation assessment
-
Tianjin, Tianjin, ChinaNational Clinical Research Center for Blood Diseases, Blood Dise
Jan 11, 2023
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)
Recruiting
- Multiple Myeloma
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 21, 2023
Heart Disease, Aging, Amyloidosis Trial in France (a basal LV septum biopsy)
Active, not recruiting
- Heart Disease
- +3 more
- a basal LV septum biopsy
-
Creteil, France
- +5 more
Sep 30, 2022
Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)
Recruiting
- Amyloid
- Amyloid Cardiomyopathy
- 18F-florbetaben PET/CT
-
Pisa, ItalyFondazione Toscana Gabriele Monasterio
Sep 16, 2023
Determine the Optimal Initial Therapy for Multiple Myeloma
Recruiting
- Multiple Myeloma
- Non-Interventional Study
-
Scottsdale, Arizona
- +3 more
Nov 22, 2023
Cardiomyopathies, Primary Trial ((18F)Flutemetamol)
Recruiting
- Cardiomyopathies, Primary
-
New Haven, ConnecticutYale University
Oct 11, 2022
Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer
Completed
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Myeloma Coach or CLL Coach Mobile App
- Springboard Beyond Cancer informational website
-
Durham, North CarolinaDuke University
Jun 23, 2023
Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction
Recruiting
- AD
- +2 more
-
Shanghai, ChinaHuashan Hospital
May 8, 2022
Alzheimer, Late Onset, Mild Cognitive Impairment, Sleep Trial in Pittsburgh (Time in Bed Restriction, Sleep Schedule)
Recruiting
- Alzheimer Disease, Late Onset
- +4 more
- Time in Bed Restriction
- Sleep Schedule
-
Pittsburgh, PennsylvaniaUPMC Western Psychiatric Hospital
Oct 25, 2022
Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)
Not yet recruiting
- Multiple Myeloma
- Immediate yoga intervention
- Delayed yoga intervention
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Sep 27, 2023
Optical Genome Mapping in Characterization of Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Bone Marrow samples collection
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Mar 15, 2023
Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)
Not yet recruiting
- Multiple Myeloma
- Plasma Cell Myeloma
- Zirconium Zr 89-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 26, 2023
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))
Suspended
- Alzheimers Disease
- +2 more
- Gantenerumab
- Matching Placebo (Gantenerumab)
-
Birmingham, Alabama
- +34 more
Jan 10, 2023
Multiple Myeloma, Amyloidosis Trial in New York (device, drug, procedure)
Active, not recruiting
- Multiple Myeloma
- Amyloidosis
- Melphalan
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 2001
-
Benowa, Queensland, AustraliaPindara Private Hospital
May 18, 2023
Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)
Not yet recruiting
- Relapsed and/or Refractory Multiple Myeloma
- BMS-986453
- +2 more
-
Köln, GermanyLocal Institution - 0017
Dec 4, 2023
High-risk Smoldering Multiple Myeloma, Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Teclistamab, Lenalidomide,
Recruiting
- High-risk Smoldering Multiple Myeloma
- +2 more
- Teclistamab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Aug 11, 2022
Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)
Recruiting
- Relapse/Refractory Multiple Myeloma
- DeepTag-GPRC5D Targeted CAR T-cells
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Venetoclax)
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- (no location specified)
Oct 30, 2023